Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The pharma last month presented early-stage data for AZD6234 at the 2024 ObesityWeek of The Obesity Society, touting an encouraging safety profile and promising weight lossthough data around the candidate remain scant.
5-Amino-1MQ showed 3540% visceral fat reduction in murine models published in Nature Metabolism (2021), but human pharmacokinetic data remains limited to small cohort studies as of 2026
If you switch back, you'll restart Wegovy's titration schedule (usually beginning at 0.5 mg or 1 mg rather than 0.25 mg if you've been on tirzepatide)
Science backed treatment Ongoing clinical support Trusted by 100k customers across the UK Lower starting doses tested: 1mg weekly: Tested in the phase 2 obesity trials as a fixed dose with no escalation
If you are interested in starting peptide therapy, you should be in good general health and have realistic expectations regarding your results
